Medicamen Biotech Shareholding Pattern
- Market cap
- ₹1.5 lakh crore
- P/E
- 22.5
- P/B
- 3.20
- ROE
- 16.4%
- Dividend yield
- 1.20%
- 52-week range
- ₹2,100.00 – ₹2,900.00
As of Jun 2026, promoters held 52.40% of Medicamen Biotech (0.00 pp from Mar 2026), foreign institutional investors 22.80%, domestic institutions 14.50% and the public 10.30%.
Source: Shareholding patterns filed with the stock exchanges (company filings). How this data is compiled.
Medicamen Biotech shareholding pattern — frequently asked questions
What is the promoter holding in Medicamen Biotech?
Promoters held 52.40% of Medicamen Biotech as of Jun 2026, unchanged from 52.40% in Mar 2026.
How much do FIIs hold in Medicamen Biotech?
Foreign institutional investors held 22.80% of Medicamen Biotech as of Jun 2026, a change of +0.30 pp from the previous quarter.
How much do domestic institutions hold in Medicamen Biotech?
Domestic institutional investors, including mutual funds and insurers, held 14.50% of Medicamen Biotech as of Jun 2026 (+0.20 pp from the previous quarter); mutual funds alone held 8.50%.
Who owns Medicamen Biotech?
As of Jun 2026, Medicamen Biotech's shareholders were promoters (52.40%), foreign institutional investors 22.80%, domestic institutions 14.50% and the public 10.30%, as filed with the stock exchanges.
Same Data For Peers
Trade Medicamen Biotech With ATS
Track MEDICAMEQ live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.